Develey Senf & Feinkost GmbH, an international manufacturer of mustard, sauces and dressings and winner of the German Sustainability Award 2020, commissioned WEHRLE in March 2021 with the design and implementation of a wastewater treatment plant with biogas generation. Just one year later, in the summer of 2022, the rapid biological commissioning of the industrial water treatment plant took place at 100% capacity at the largest German production site in Dingolfing.
TECNOMYL S.A. commissions WEHRLE with the construction of a BIOMEMBRAT® MBR for the treatment of wastewater from the production of agricultural pesticides.
The Paraguayan company TECNOMYL S.A. is a leading manufacturer and supplier of agricultural pesticides in Paraguay. After two years of joint work, the company has contracted WEHRLE to build a new plant for the treatment of its production wastewater. After the laboratory tests performed in Germany and the subsequent on-site piloting, which was carried out together with WEHRLE’s Brazilian cooperation partner Ambiensys, TECNOMYL was convinced of the benefits of WEHRLE’s technology.
In Malaysia a waste management company operates a landfill for the disposal of residual materials from several waste management companies. Due to the wide range and high degree of contamination of the leachate of this landfill is very complex and difficult to treat. The high concentrations of salts and nitrogenous organic compounds are expecting to be increased due to the increase of waste production and can only be oxidized or eliminated by combining different process steps.
In April 2020, the German wastewater treatment expert WEHRLE signed the contract for the establishment of a new hub in Kula Lumpur, Malaysia. Having received the business and trading licenses at the beginning of 2021, the subsidiary called “WEHRLE Asia Sdn. Bhd.” is now ready for doing business.
March 2021 – An international syrup producer has awarded the contract for the extension and upgrade of its existing wastewater treatment plant at the production site in Kuala Lumpur, Malaysia, to the plant engineering company WEHRLE, based in Southern Germany.
TEVA – one of the world’s leading ten manufacturers of pharmaceuticals and owner of RATIOPHARM since 2010, as well as global market leader for generics – is investing approximately € 500 million for the large-scale production of state-of-the-art biotechnological active ingredients in Southern Germany.
The pandemic brings along new challenges, like, for example, the commissioning of state-of-the-art wastewater treatment plants in distant regions in times of travel restrictions: another task that WEHRLE has successfully mastered!
Pharmaceutical wastewater treatment expert WEHRLE from Germany predicts a good year 2021 for its business: “In the past years we have shown how effectively and reliably wastewater from drugs production can be treated – with compact treatment plants that eliminate and adsorb Trace Organic Contaminants respectively Active Pharmaceutical Ingredients efficiently at low operation costs. At the moment we see three development vectors that influencing our business of effluent treatment in the pharma industry: